Can TGF-β1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?

被引:32
|
作者
Kuh, Sung Uk [2 ]
Zhu, Yerun [3 ]
Li, Jun [3 ]
Tsai, Kai-Jow [3 ]
Fei, Qinming [3 ]
Hutton, William C. [1 ,3 ]
Yoon, S. Tim [3 ]
机构
[1] Emory Orthopaed & Spine Ctr, Atlanta, GA 30329 USA
[2] Yonsei Univ, Coll Med, Spine & Spinal Cord Inst, Dept Neurosurg, Seoul, South Korea
[3] Emory Univ, Sch Med, Vet Affairs Med Ctr, Dept Orthopaed, Atlanta, GA USA
关键词
Proteoglycan; Bone marrow derived cells; TGF-beta(1); rhBMP-2;
D O I
10.1007/s00701-008-0029-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The recombinant human bone morphogenic protein-2 (rhBMP-2) is known to increase the proteoglycan production and chondrogenic gene expression in the disc cells. The transforming growth factor-beta 1 (TGF-beta(1)) can transform the bone marrow stem cells (BMDCs) into the disc-like cells. Materials and methods We carried out an experiment to determine if TGF-beta(1) and rhBMP-2 can act in synergy on BMDCs by increasing the production of sulfated-glycosaminoglycan (sGAG) and affecting the mRNA expression of aggrecan, type I collagen, and type II collagen. The BMDCs were isolated from the iliac crest and femur of a New Zealand white rabbit (1 year). The BMDCs were culured in monolayer and treated for 6 days with TGF-beta(1) 10 ng/ml (group 1), rhBMP-2 200 ng/ml (group 2), and both TGF-beta(1) 10 ng/ml and rhBMP-2 200 ng/ml (group 3: the combined group) in Dulbecco's modified Eagle medium/F-12 with 1% fetal bovine serum. After 6 days, the sGAG content in the media was quantified using 1,9-dimethylmethylene blue staining and the mRNA expression of aggrecan, type I collagen, type II collagen, Sox-9, BMP-2, and BMP-7 were measured with the real-time PCR. The same BMDCs were also cultured in the chamber slide at 3x10(4) cells/chamber. After 6 days treatment, the treated cells were immunofluorescence stained with aggrecan, type I collagen, type II collagen, anti-BMP-2, anti-BMP-7 antibodies. After that, we compared the number of positive immunofluorescence stained cells with fluorescence microscope. The sGAG production and mRNA expression for each group were normalized against the same parameters for a non-treatment group. Results and discussion The sGAG production was increased 1.15*, 1.34*, and 1.45* times in the TGF-beta(1) 10 ng/ml group, the rhBMP-2 200 ng/ml group, and the combined group respectively. The mRNA expression of aggrecan was increased 1.28, 3.42*, and 5.34* times, the mRNA expression of type I collagen was increased 0.86, 1.09, 1.17 times, the mRNA expression of type II collagen was increased 3.58*, 3.77*, and 10.78* times, the mRNA expression of Sox-9 was increased 1.29, 2.45, 2.75* times, the mRNA expression of BMP-2 was increased 1.14, 2.07, 4.43* times, and the mRNA expression of BMP-7 was increased 1.16, 1.49, 1.97* times, respectively for each group (* indicates p < 0.05). On the immunofluorescence staining of antibodies, the average positively immunofluorescence stained cells number for aggrecan were 4.2, 15.8*, 10*, and 22* according to the non-treatment group, TGF-beta(1) 10 ng/ml group, rhBMP-2 200 ng/ml group, and the combined group respectively. The average positively immunofluorescence stained cells number for type I collagen were 7, 14.2*, 9.2*, 17.4* and the average positively immunofluorescence stained cells number for type II collagen were 8.5, 28.25*, 20.25*, 42.25* and the average positively immunofluorescence stained cells number for anti-BMP-2 were 5, 16.75*, 8.75*, 27.25* and the average positively immunofluorescence stained cells number for anti-BMP-7 were 3.25, 7.5*, 8.75*, 15.25* (* indicates p < 0.05). Conclusions Both TGF-beta(1) and rhBMP-2 alone, can increase proteoglycan production in the BMDCs. However, if they were used in combination, there is a synergistic effect. Similarly, the mRNA expressions of both aggrecan, type II collagen, Sox-9, BMP-2, and BMP-7 except for type I collagen were increased significantly when TGF-beta(1) and rhBMP-2 were combined. The positive immunofluorescence stained cell numbers for aggrecan, type I, II collagen, BMP-2 and BMP-7 were also increased after each TGF-beta(1) and rhBMP-2 treatment, and also more increased significantly in the aggrecan, type I, II collagen, BMP-2, and 7 when they were used jointly.
引用
下载
收藏
页码:1073 / 1079
页数:7
相关论文
共 50 条
  • [21] THE EFFECTS OF beta-TCP/rhBMP-2 ON BONE FORMATION IN OSTEOBLAST-LIKE CELLS INDUCED FROM BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
    Choi, Yong-Soo
    Hwang, Kyung-Gyun
    Lee, Jae-Seon
    Park, Chang-Joo
    Shim, Kwang-Sup
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2008, 34 (04) : 419 - 427
  • [22] Effect of bone marrow mesenchymal stem cells on the TGF-β1/Smad signaling pathway of hepatic stellate
    Sun, X. E.
    Zhang, X. Q.
    Liu, M. M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 8744 - 8754
  • [23] Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim)
    Balk, ML
    Bray, J
    Day, C
    Epperly, M
    Greenberger, J
    Evans, CH
    Niyibizi, C
    BONE, 1997, 21 (01) : 7 - 15
  • [24] Associations between TGF-β1 receptors in human bone marrow stromal cells
    Robledo, MM
    Ursa, MA
    Sánchez-Madrid, F
    Teixidó, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) : 804 - 811
  • [25] TGF-β1-binding proteins on human bone marrow stromal cells
    Robledo, MM
    Teixidó, J
    LEUKEMIA & LYMPHOMA, 1997, 27 (5-6) : 509 - 515
  • [26] TGF-β1 induces senescence of bone marrow mesenchymal stem cells via increase of mitochondrial ROS production
    Wu, Junfang
    Niu, Jie
    Li, Xiaopeng
    Wang, Xianwei
    Guo, Zhikun
    Zhang, Fenxi
    BMC DEVELOPMENTAL BIOLOGY, 2014, 14
  • [27] Effect of IGF-1 in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-β signaling
    Longobardi, L
    O'Rear, L
    Aakula, S
    Johnstone, B
    Shimer, K
    Chytil, A
    Horton, WA
    Moses, HL
    Spagnoli, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) : 626 - 636
  • [28] TGF-β TYPE II RECEPTOR AS A NOVEL INDICATOR OF CHONDROGENESIS IN EQUINE BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
    Suter, K. K.
    Payne, K. A.
    Yao, V.
    Fortier, L. A.
    Chu, C. R.
    OSTEOARTHRITIS AND CARTILAGE, 2011, 19 : S115 - S116
  • [29] Role of TGF-? 3 and bone marrow mesenchymal stem cells on regeneration of myometrial injury in rats
    Yang, Jing
    Chen, Zhengyong
    Li, Shuang
    Yang, Yingchun
    Liao, Yuan
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2022, 15 (04)
  • [30] Glycitin regulates osteoblasts through TGF-β or AKT signaling pathways in bone marrow stem cells
    Zhang, Liyan
    Chen, Jiying
    Chai, Wei
    Ni, Min
    Sun, Xin
    Tian, Dan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (05) : 3063 - 3067